Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-279726

Director acquired 29,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BERGER FRANKLIN M Director 2026-06-18 Option exercise +29,600 536,097 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BERGER FRANKLIN M Director 2026-06-18 Option exercise · Restricted Stock Units −29,600 0 D: show line 2 in the form
BERGER FRANKLIN M Director 2026-06-18 Grant or award · Restricted Stock Units +26,700 26,700 D: show line 3 in the form
BERGER FRANKLIN M Director 2026-06-18 Grant or award · Stock Option (Right to Buy) +37,700 37,700 D: show line 4 in the form
Loading xslF345X06/ownership.xml…